Cargando…

Incremental Health Care Resource Utilization and Economic Burden of Venous Thromboembolism Recurrence from a U.S. Payer Perspective

BACKGROUND: The third leading cause of cardiovascular-associated death, venous thromboembolism (VTE), represents a significant health care and economic burden. Although the burden of a one-time VTE event has been assessed, there are limited data regarding the burden of VTE recurrence. OBJECTIVES: To...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, J., Lingohr-Smith, M., Kwong, W.J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Academy of Managed Care Pharmacy 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438350/ https://www.ncbi.nlm.nih.gov/pubmed/24456319 http://dx.doi.org/10.18553/jmcp.2014.20.2.174

Ejemplares similares

Incremental Health Care Burden of Bleeding Among Patients with Venous Thromboembolism in the United States
por: Amin, Alpesh, et al.
Publicado: (2015)

The economic burden of pulmonary arterial hypertension (PAH) in the US on payers and patients
por: Sikirica, Mirko, et al.
Publicado: (2014)

Incremental increases in economic burden parallels cardiometabolic risk factors in the US
por: McQueen, R Brett, et al.
Publicado: (2016)

Application of Economic Analyses in U.S. Managed Care Formulary Decisions: A Private Payer's Experience
por: Watkins, John B., et al.
Publicado: (2006)

Assessing the Economic Burden and Health Care Utilizations of U.S. Veteran Patients with Schizophrenia
por: Xie, Lin, et al.
Publicado: (2013)

Healthcare resource use and cost burden of urinary incontinence to United States payers
por: Datar, Manasi, et al.
Publicado: (2022)

Hospital Resource Utilization and Costs Associated With Warfarin Versus Apixaban Treatment Among Patients Hospitalized for Venous Thromboembolism in the United States
por: Deitelzweig, Steven, et al.
Publicado: (2018)

Values-Based Foundation for a U.S. Single Payer Health System Model
por: Markowitz, Walter, et al.
Publicado: (2021)

Comparative Clinical and Economic Outcomes Associated with Warfarin Versus Apixaban in the Treatment of Patients with Venous Thromboembolism in a Large U.S. Commercial Claims Database
por: Guo, Jennifer D., et al.
Publicado: (2020)

Current and projected future economic burden of Parkinson’s disease in the U.S.
por: Yang, Wenya, et al.
Publicado: (2020)

An Economic Evaluation of Tofacitinib Treatment in Rheumatoid Arthritis After Methotrexate or After 1 or 2 TNF Inhibitors from a U.S. Payer Perspective
por: Claxton, Lindsay, et al.
Publicado: (2018)

Effectiveness and Safety of Apixaban versus Warfarin as Outpatient Treatment of Venous Thromboembolism in U.S. Clinical Practice
por: Weycker, Derek, et al.
Publicado: (2018)

Economic burden of lung cancer in Turkey: a cost of illness study from payer perspective
por: Cicin, Irfan, et al.
Publicado: (2021)

Comment on: “Cost-Utility Analysis of Duloxetine in Osteoarthritis: A US Private Payer Perspective”
por: Liedgens, Hiltrud, et al.
Publicado: (2013)

Burden of venous thromboembolism in patients with pancreatic cancer
por: Frere, Corinne
Publicado: (2021)

Incremental cost of premature birth – a public health care payer perspective from Hungary
por: Kovács, Gábor, et al.
Publicado: (2023)

Erratum: Effectiveness and Safety of Apixaban versus Warfarin as Outpatient Treatment of Venous Thromboembolism in U.S. Clinical Practice
por: Weycker, Derek, et al.
Publicado: (2018)

Review of the cost of venous thromboembolism
por: Fernandez, Maria M, et al.
Publicado: (2015)

US Health Resource Utilization and Cost Burden Associated with Choroideremia
por: Dong, Shaobin, et al.
Publicado: (2021)

Persistent Symptoms of Dengue: Estimates of the Incremental Disease and Economic Burden in Mexico
por: Tiga, D. Carolina, et al.
Publicado: (2016)

U.S.-México economic relations /
Publicado: (1979)

Circumstances of provoked recurrent venous thromboembolism: the Austrian study on recurrent venous thromboembolism
por: Puhr, Hannah C., et al.
Publicado: (2019)

Particulate Matter Exposure and Preterm Birth: Estimates of U.S. Attributable Burden and Economic Costs
por: Trasande, Leonardo, et al.
Publicado: (2016)

Economic Burden of Treatment-Resistant Depression in Privately Insured U.S. Patients with Physical Conditions
por: Zhdanava, Maryia, et al.
Publicado: (2020)

Use of Oritavancin in Moderate-to-Severe ABSSSI Patients Requiring IV Antibiotics: A U.S. Payer Budget Impact Analysis
por: Jensen, Ivar S., et al.
Publicado: (2016)

Payer perceptions on the use of economic models in oncology decision making
por: Biskupiak, Joseph, et al.
Publicado: (2021)

Benchmarking HIV Quality Measures Across US Payer Types
por: Priest, Julie L., et al.
Publicado: (2020)

Comparing the burden of illness in patients with alopecia areata vs atopic dermatitis in the US population from a payer perspective
por: Fenske, D. Christian, et al.
Publicado: (2023)

Economic burden of venous thromboembolism in surgical patients: A propensity score analysis from the national claims database in Vietnam
por: Bui, My Hanh, et al.
Publicado: (2020)

Economic Evaluation of Direct Oral Anticoagulants Compared to Warfarin for Venous Thromboembolism in Thailand: A Cost-Utility Analysis
por: Niyomsri, Siwaporn, et al.
Publicado: (2023)

Venous Thromboembolism Prophylaxis and Risk for Acutely Medically Ill Patients Stratified by Different Ages and Renal Disease Status
por: Amin, Alpesh, et al.
Publicado: (2019)

The burden of selected cancers in the US: health behaviors and health care resource utilization
por: Iadeluca, Laura, et al.
Publicado: (2017)

Economic Costs of Diabetes in the U.S. in 2012
Publicado: (2013)

Economic Costs of Diabetes in the U.S. in 2017
Publicado: (2018)

Healthcare Resource Utilization for Oral Anticoagulant Reversal Therapies in Non-Valvular Atrial Fibrillation/Venous Thromboembolism Patients
por: Spyropoulos, Alex C., et al.
Publicado: (2022)

Economic Burden of Informal Caregiving Associated With History of Stroke and Falls Among Older Adults in the U.S.
por: Joo, Heesoo, et al.
Publicado: (2017)

Economic burden, financial stress, and cost-related coping among people with uncontrolled diabetes in the U.S
por: Patel, Minal R., et al.
Publicado: (2023)

Patterns of Care in Patients with Metastatic Renal Cell Carcinoma Among a U.S. Payer Population with Commercial or Medicare Advantage Membership
por: Miller, Lesley-Ann, et al.
Publicado: (2016)

Incremental Healthcare Utilization and Cost Burden of Comorbid Insomnia in Alzheimer’s Disease Patients
por: Qureshi, Zaina P., et al.
Publicado: (2021)

Utilization of Mental Health Resources and Complementary and Alternative Therapies for Alopecia Areata: A U.S. Survey
por: Hussain, Salman T, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_3ce8bkmkgkudne5h7cq38f3s48